Year | Citation | Score | |||
---|---|---|---|---|---|
2014 | Mergy MA, Gowrishankar R, Gresch PJ, Gantz SC, Williams J, Davis GL, Wheeler CA, Stanwood GD, Hahn MK, Blakely RD. The rare DAT coding variant Val559 perturbs DA neuron function, changes behavior, and alters in vivo responses to psychostimulants. Proceedings of the National Academy of Sciences of the United States of America. 111: E4779-88. PMID 25331903 DOI: 10.1073/Pnas.1417294111 | 0.468 | |||
2014 | Mergy MA, Gowrishankar R, Davis GL, Jessen TN, Wright J, Stanwood GD, Hahn MK, Blakely RD. Genetic targeting of the amphetamine and methylphenidate-sensitive dopamine transporter: on the path to an animal model of attention-deficit hyperactivity disorder. Neurochemistry International. 73: 56-70. PMID 24332984 DOI: 10.1016/j.neuint.2013.11.009 | 0.494 | |||
2012 | Sakrikar D, Mazei-Robison MS, Mergy MA, Richtand NW, Han Q, Hamilton PJ, Bowton E, Galli A, Veenstra-Vanderweele J, Gill M, Blakely RD. Attention deficit/hyperactivity disorder-derived coding variation in the dopamine transporter disrupts microdomain targeting and trafficking regulation. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 32: 5385-97. PMID 22514303 DOI: 10.1523/Jneurosci.6033-11.2012 | 0.474 | |||
Show low-probability matches. |